Evidence map›Paper›PMID 37247944›Full record

ArticleBMJ open quality2023

Implementation of medication reconciliation in outpatient cancer care.

Melanie Powis, Celina Dara, Alyssa Macedo, Saidah Hack, Lucy Ma, Ernie Mak, Lyndon Morley, Vishal Kukreti, Hemangi Dave, Ryan Kirkby and 1 more

Abstract read
In one paragraph

Article in BMJ open quality, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Melanie PowisCancer Quality Lab, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
Celina DaraCancer Quality Lab, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
Alyssa MacedoCancer Quality Lab, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
Saidah HackCancer Quality Lab, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
Lucy MaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
Ernie MakCancer Quality Lab, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
Lyndon MorleyDepartment of Radiation Medicine, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
Vishal KukretiCancer Quality Lab, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
Hemangi DavePharmacy, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
Ryan KirkbyCancer Quality Lab, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.ORCID 0009-0005-6782-4279
Monika K KrzyzanowskaCancer Quality Lab, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada monika.krzyzanowska@uhn.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedication reconciliation (MedRec) is a process where providers work with patients to document and communicate comprehensive medication information by creating a complete medication list (best possible medication history (BPMH)) then reconciling it against what patient is actually taking to identify potential issues such as drug-drug interactions. We undertook an environmental scan of current MedRec practices in outpatient cancer care to inform a quality improvement project at our centre with the aim of 30% of patients having a BPMH or MedRec within 30 days of initiating treatment with systemic therapy.

methodsWe conducted semi-structured interviews with key stakeholders from 21 cancer centres across Canada, probing on current policies, and barriers and facilitators to MedRec. Guided by the findings of the scan, we then undertook a quality improvement project at our cancer centre, comprising six iterative improvement cycles.

resultsMost institutions interviewed had a process in place for collecting a BPMH (81%) and targeted patients initiating systemic therapy (59%); however, considerable practice variation was noted and completion of full MedRec was uncommon. Lack of resources, high patient volumes, lack of a common medical record spanning institutions and settings which limits access to medication records from external institutions and community pharmacies were identified as significant barriers. Despite navigating challenges related to the COVID-19 pandemic, we achieved 26.6% of eligible patients with a documented BPMH. However, uptake of full MedRec remained low whereby 4.7% of patients had a documented MedRec.

conclusionsRealising improvements to completion of MedRec in outpatient cancer care is possible but takes considerable time and iteration as the process is complex. Resource allocation and information sharing remain major barriers which need to be addressed in order to observe meaningful improvements in MedRec.

Indexed as

COVID-19NeoplasmsElectronic Health RecordsHumansMedication ReconciliationOutpatientsPandemicsadverse events, epidemiology and detectionmedication reconciliationmedication safety

Identifiers

PMID37247944
PMCPMC10230967

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.